These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2196085)
21. Cyclosporin A serum and blood levels in marrow graft recipients: correlation with administered dose, serum creatinine and graft-versus-host disease. Bacigalupo A; Di Giorgio F; Frassoni F; Van Lint MT; Raffo MR; Gogioso L; Viale M; Marmont AM Acta Haematol; 1984; 72(3):155-62. PubMed ID: 6438979 [TBL] [Abstract][Full Text] [Related]
22. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801 [TBL] [Abstract][Full Text] [Related]
23. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Berg KJ; Førre O; Bjerkhoel F; Amundsen E; Djøseland O; Rugstad HE; Westre B Kidney Int; 1986 Jun; 29(6):1180-7. PubMed ID: 3528611 [TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome. Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268 [TBL] [Abstract][Full Text] [Related]
25. Treatment of PUVA- and retinoid-PUVA-resistant severe psoriasis with systemic cyclosporin A. Takashima A; Morita A; Tsuji T J Dermatol; 1990 Aug; 17(8):482-8. PubMed ID: 2229652 [TBL] [Abstract][Full Text] [Related]
26. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. Maza A; Montaudié H; Sbidian E; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP; Paul C J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():19-27. PubMed ID: 21388455 [TBL] [Abstract][Full Text] [Related]
37. Renal side-effects of cyclosporin A with special reference to autoimmune diseases. Mihatsch MJ; Thiel G; Ryffel B Br J Dermatol; 1990 Jun; 122 Suppl 36():101-15. PubMed ID: 2196077 [TBL] [Abstract][Full Text] [Related]
38. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center. Tinawi M; Miller L; Bastani B Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686 [TBL] [Abstract][Full Text] [Related]
39. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A. Schopf RE; Hultsch T; Lotz J; Bräutigam M J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of cyclosporin A in psoriasis: a summary of the United States' experience. Fradin MS; Ellis CN; Voorhees JJ Br J Dermatol; 1990 Jun; 122 Suppl 36():21-5. PubMed ID: 2196080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]